ADHD Medication Shortages: 2026 Update

In 2026, the UK ADHD medication shortage remains a chronic challenge. While some strengths of medication have seen intermittent recovery, the situation continues to be described by the NHS as fragile and unstable due to a permanent shift in global demand and ongoing manufacturing constraints.

Current Stock Status and Volatility

The supply of ADHD medicines remains problematic across the country. While medication can now be restarted for many patients who were previously affected, the system is not yet in a position to easily accommodate those newly diagnosed. Lisdexamfetamine, commonly known as Elvanse, has seen some strengths return to stock, but intermittent regional outages persist. Methylphenidate products such as Concerta XL and Xaggitin XL remain the most volatile, with different strengths frequently dropping in and out of availability. Guanfacine and Atomoxetine are currently more stable, though they cannot easily absorb the excess demand from patients unable to access stimulant medications.

The Role of Serious Shortage Protocols

In 2026, the NHS continues to rely on Serious Shortage Protocols to manage the crisis. These legal measures empower your pharmacist to provide a bioequivalent brand or a different strength of your medication without requiring you to return to your GP for a new prescription. For example, if a specific brand of prolonged release methylphenidate is unavailable, the pharmacist may be able to substitute it with an alternative brand that is medically interchangeable. This flexibility is essential for reducing delays, though it does mean patients may receive different packaging or tablet types from month to month.

Practical Advice for Patients and Families

NHS guidance for 2026 continues to advise patients to request repeat prescriptions at least two to three weeks before their current supply runs out to allow pharmacies time to source stock. It is often helpful to contact several local pharmacies, as stock levels vary significantly between locations, and smaller independent chemists frequently have access to different wholesalers than the major high street chains. For those taking stimulant medication, clinicians may suggest planned treatment breaks during weekends or school holidays to stretch existing supplies, provided this is safe for the individual. However, this should never be done with Guanfacine, which must be tapered slowly under medical supervision.